Vericiguat: a fifth cornerstone in the treatment of heart failure with reduced ejection fraction?

ESC Heart Fail. 2023 Dec;10(6):3735-3738. doi: 10.1002/ehf2.14549. Epub 2023 Oct 8.

Authors

Andreas Hammer¹, Alexander Niessner¹, Patrick Sulzgruber¹

Affiliation

¹ Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Vienna, Austria.

No abstract available

Publication types

Letter

MeSH terms

Heart Failure* / drug therapy
Heterocyclic Compounds, 2-Ring*
Humans
Stroke Volume
Treatment Outcome

Substances

vericiguat
Heterocyclic Compounds, 2-Ring